Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    HER2 Expression in Urothelial Carcinoma (UC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Early Diagnosis Improvement of Chlamydia Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Addressing Healthcare Disparities in the Outpatient Diagnosis and Management of COVID-19
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Treating Older Patients with HR+/HER2- Metastatic Breast Cancer (mBC): Best Practices for Their Assessment and Care
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Treating the Whole Patient: Considerations for Patients with HR+/HER2- Metastatic Breast Cancer (mBC) and Existing Comorbidities
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Optimizing Testing and Treatment in Metastatic Colorectal Cancer (mCRC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Closing the Gaps within Intestinal Ultrasound
    Release Date:
    Partner: International Bowel Ultrasound Group
    Review Process: Expert Review Panel
    Research Inflammation & Immunology All
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Addressing Knowledge Gaps in Aplastic Anemia
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Gene and Gene-modified Cell Therapies Medical Education
    Release Date:
    Partner: American Society of Gene + Cell Therapy
    Review Process: Expert Review Panel
    Education Rare Disease All
    Education for Improvement of Early Detection and Appropriate Anticoagulant Therapy for Atrial Fibrillation
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Education Internal Medicine Japan
    Efforts to Improve Quality of Migraine Medical Care
    Release Date:
    Partner: The Japanese Headache Society
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Education Internal Medicine Japan
    Pathological diagnosis and Immunohistochemistry biomarker assessments of Breast Cancer
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology Ghana
    Evolving Treatment Options in First-line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology All
    Promoting Understanding of COVID-19 and Vaccination and Improving Communication Skills for Healthcare Professionals
    Release Date:
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Vaccines Japan
    American Headache Society Quality Improvement Competitive Grant Program
    Release Date:
    Partner: American Headache Society
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine USA
    Boosting Oncology Opportunities for Support programs and Treatment, (BOOST), An Oncology Quality Boosting Program
    Release Date:
    Review Process: Expert Review Panel
    Translation:(link)
    Quality Improvement Oncology Netherlands
    Understanding the Mechanisms and Formulating the Optimal Management of Hematological Toxicity of PARPi
    Release Date:
    Partner: National Comprehensive Cancer Network
    Review Process: Expert Review Panel
    Research Oncology USA
    Improving Care for Patients with Recurrent/Metastatic (R/M) Cervical Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Enhancing HCPs’ Preparedness: Maternal Immunization Knowledge Updates
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA